Glucose Monitoring Devices Market By Device, By Patient Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Glucose Monitoring Devices Market

The glucose monitoring devices market was valued at $14.7 billion in 2023 and is projected to reach $38.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

Glucose monitoring involves the measuring and tracking the glucose levels in the blood or interstitial fluid of individuals. It is an essential routine for individuals with diabetes for effective management, as it provides data about fluctuations in blood sugar levels throughout the day in response to several factors such as food intake, stress, physical activity, and medication. The real-time or periodic glucose readings provided glucose monitoring devices allow individuals to make informed decisions regarding dietary choices, medication dosage, and lifestyle adjustments. Glucose monitoring devices are critical equipment for the prevention of short-term and long-term complications associated with diabetes.

Increase in prevalence of lifestyle diseases, including obesity and diabetes, is a major driver of the glucose monitoring devices market. In addition, the demand for self-monitoring portable devices is surging among individuals, hence augmenting the development of the market. Non-invasive glucose monitoring devices are trending in the market currently. Optical sensors and microneedle patches are among the most common equipment available in the market. Furthermore, the integration of data analytics is acquiring traction from individuals and healthcare providers as it aids to identify patterns and trends, thereby assisting in proactive management and prevention of diseases.

However, a large base of individuals adheres to the traditional method of glucose testing owing to high confidence in its results, which presents challenges for the widespread adoption of new & innovative glucose monitoring devices. Moreover, the approval process of new monitoring devices is highly stringent and lengthy, which often delays the introduction of novel products into the market. Contrarily, the constant efforts of scientists to launch innovative products present lucrative opportunities for the expansion of the market. For instance, researchers of the King Abdullah University of Science & Technology, Saudi Arabia developed a prototype for a sensor that measures glucose levels using saliva. This device is projected to be a simple, quick, and painless way for individuals to measure blood glucose in the future.

Segment Review

The glucose monitoring devices market is segmented into device, patient type, end user, and region. On the basis of device, the market is divided into blood glucose meters, continuous glucose monitoring systems, flash glucose monitoring systems, smartphone apps, and wearables. By patient type, it is bifurcated into type 1 diabetes and type 2 diabetes. According to end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of device, the continuous glucose monitoring devices segment generated the highest revenue in the market in 2023.

By patient type, the type 1 diabetes segment was the highest shareholder in 2023.

According to end user, the home care settings segment was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global glucose monitoring devices market include Menarini Diagnostics S.R.L., Senseonics, A., Novo Nordisk A/S, GlySens Incorporated, Johnson & Johnson, DexCom, Inc., Medtronic plc, F. Hoffman-La Roche Ltd, Abbott laboratories, and B. Braun SE. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data

Key Market Segments

By Device

Blood Glucose Meters
Continuous Glucose Monitoring Systems
Flash Glucose Monitoring Systems
Smartphone Apps and Wearables

By Patient Type

Type 1 Diabetes
Type 2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Menarini Diagnostics S.R.L.
Senseonics, A.
Novo Nordisk A/S
GlySens Incorporated
Johnson & Johnson
DexCom, Inc.
Medtronic plc
F. Hoffman-La Roche Ltd
Abbott laboratories
B. Braun SE

Product Code: A62953

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities

CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Device
4.2. Blood Glucose Meters
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Continuous Glucose Monitoring Systems
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Flash Glucose Monitoring Systems
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Smartphone Apps And Wearables
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country

CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Patient Type
5.2. Type 1 Diabetes
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Type 2 Diabetes
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Home Care Settings
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Device
- 7.2.3. Market Size and Forecast, By Patient Type
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Glucose Monitoring Devices Market
  - 7.2.6.1. Market Size and Forecast, By Device
  - 7.2.6.2. Market Size and Forecast, By Patient Type
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Glucose Monitoring Devices Market
  - 7.2.7.1. Market Size and Forecast, By Device
  - 7.2.7.2. Market Size and Forecast, By Patient Type
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Glucose Monitoring Devices Market
  - 7.2.8.1. Market Size and Forecast, By Device
  - 7.2.8.2. Market Size and Forecast, By Patient Type
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Device
- 7.3.3. Market Size and Forecast, By Patient Type
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Glucose Monitoring Devices Market
  - 7.3.6.1. Market Size and Forecast, By Device
  - 7.3.6.2. Market Size and Forecast, By Patient Type
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Glucose Monitoring Devices Market
  - 7.3.7.1. Market Size and Forecast, By Device
  - 7.3.7.2. Market Size and Forecast, By Patient Type
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Glucose Monitoring Devices Market
  - 7.3.8.1. Market Size and Forecast, By Device
  - 7.3.8.2. Market Size and Forecast, By Patient Type
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Glucose Monitoring Devices Market
  - 7.3.9.1. Market Size and Forecast, By Device
  - 7.3.9.2. Market Size and Forecast, By Patient Type
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Glucose Monitoring Devices Market
  - 7.3.10.1. Market Size and Forecast, By Device
  - 7.3.10.2. Market Size and Forecast, By Patient Type
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Glucose Monitoring Devices Market
  - 7.3.11.1. Market Size and Forecast, By Device
  - 7.3.11.2. Market Size and Forecast, By Patient Type
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Device
- 7.4.3. Market Size and Forecast, By Patient Type
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Glucose Monitoring Devices Market
  - 7.4.6.1. Market Size and Forecast, By Device
  - 7.4.6.2. Market Size and Forecast, By Patient Type
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Glucose Monitoring Devices Market
  - 7.4.7.1. Market Size and Forecast, By Device
  - 7.4.7.2. Market Size and Forecast, By Patient Type
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Glucose Monitoring Devices Market
  - 7.4.8.1. Market Size and Forecast, By Device
  - 7.4.8.2. Market Size and Forecast, By Patient Type
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Glucose Monitoring Devices Market
  - 7.4.9.1. Market Size and Forecast, By Device
  - 7.4.9.2. Market Size and Forecast, By Patient Type
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Glucose Monitoring Devices Market
  - 7.4.10.1. Market Size and Forecast, By Device
  - 7.4.10.2. Market Size and Forecast, By Patient Type
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market
  - 7.4.11.1. Market Size and Forecast, By Device
  - 7.4.11.2. Market Size and Forecast, By Patient Type
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Device
- 7.5.3. Market Size and Forecast, By Patient Type
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Glucose Monitoring Devices Market
  - 7.5.6.1. Market Size and Forecast, By Device
  - 7.5.6.2. Market Size and Forecast, By Patient Type
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Glucose Monitoring Devices Market
  - 7.5.7.1. Market Size and Forecast, By Device
  - 7.5.7.2. Market Size and Forecast, By Patient Type
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Glucose Monitoring Devices Market
  - 7.5.8.1. Market Size and Forecast, By Device
  - 7.5.8.2. Market Size and Forecast, By Patient Type
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Glucose Monitoring Devices Market
  - 7.5.9.1. Market Size and Forecast, By Device
  - 7.5.9.2. Market Size and Forecast, By Patient Type
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Menarini Diagnostics S.R.L.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Senseonics, A.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Novo Nordisk A/S
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. GlySens Incorporated
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Johnson And Johnson
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. DexCom, Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. Medtronic Plc
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. F. Hoffman-La Roche Ltd
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Abbott Laboratories
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. B. Braun SE
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments